TY - JOUR
T1 - Paratope Duality and Gullying are Among the Atypical Recognition Mechanisms Used by a Trio of Nanobodies to Differentiate Ebolavirus Nucleoproteins
AU - Sherwood, Laura Jo
AU - Taylor, Alexander Bryan
AU - Hart, Peter John
AU - Hayhurst, Andrew
N1 - Funding Information:
This work was supported by National Institutes of Health (NIH) , National Institute of Allergy and Infectious Diseases R21AI105568 (AH) and R01AI112851 (AH), Texas Biomedical Research Institute Forum (AH) and was conducted in facilities constructed with support from the Office of Research Infrastructure Programs (ORIP) of the NIH through grant C06 RR012087 . This work is based on research conducted at the Northeastern Collaborative Access Team beamlines, which are funded by the National Institute of General Medical Sciences from the NIH ( P41 GM103403 ). The Pilatus 6 M detector on 24-ID-C beamline is funded by a NIH-ORIP HEI grant ( S10 RR029205 ). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. The X-Ray Crystallography Core Laboratory is a part of the Institutional Research Cores supported by the Office of the Vice President for Research and the UT Health Mays Cancer Center (NIH/NCI grant P30 CA054174 ). P.J.H. was funded by the Robert A. Welch Foundation grant AQ-1399. Appendix A
Funding Information:
This work was supported by National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases R21AI105568 (AH) and R01AI112851 (AH), Texas Biomedical Research Institute Forum (AH) and was conducted in facilities constructed with support from the Office of Research Infrastructure Programs (ORIP) of the NIH through grant C06 RR012087. This work is based on research conducted at the Northeastern Collaborative Access Team beamlines, which are funded by the National Institute of General Medical Sciences from the NIH (P41 GM103403). The Pilatus 6 M detector on 24-ID-C beamline is funded by a NIH-ORIP HEI grant (S10 RR029205). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. The X-Ray Crystallography Core Laboratory is a part of the Institutional Research Cores supported by the Office of the Vice President for Research and the UT Health Mays Cancer Center (NIH/NCI grant P30 CA054174). P.J.H. was funded by the Robert A. Welch Foundation grant AQ-1399.
Publisher Copyright:
© 2019 The Author(s)
PY - 2019/12/6
Y1 - 2019/12/6
N2 - We had previously shown that three anti–Marburg virus nanobodies (VHH or single-domain antibody [sdAb]) targeted a cryptotope within an alpha-helical assembly at the nucleoprotein (NP) C-terminus that was conserved through half a century of viral evolution. Here, we wished to determine whether an anti–Ebola virus sdAb, that was cross-reactive within the Ebolavirus genus, recognized a similar structural feature upstream of the ebolavirus NP C-terminus. In addition, we sought to determine whether the specificities of a less cross-reactive anti–Zaire ebolavirus sdAb and a totally specific anti–Sudan ebolavirus sdAb were the result of exclusion from this region. Binding and X-ray crystallographic studies revealed that the primary determinant of cross-reactivity did indeed appear to be a preference for the helical feature. Specificity, in the case of the Zaire ebolavirus–specific sdAb, arose from the footprint shifting away from the helices to engage more variable residues. While both sdAbs used CDRs, they also had atypical side-on approaches, with framework 2 helping to accommodate parts of the epitope in sizeable paratope gullies. The Sudan ebolavirus–specific sdAb was more remarkable and appeared to bind two C-terminal domains simultaneously via nonoverlapping epitopes—“paratope duality.” One mode involved paratope gullying, whereas the other involved only CDRs, with CDR3 restructuring to wedge in between opposing walls of an interdomain crevice. The varied routes used by sdAbs to engage antigens discovered here deepen our appreciation of the small scaffold's architectural versatility and also reveal lucrative opportunities within the ebolavirus NP C-termini that might be leveraged for diagnostics and novel therapeutic targeting.
AB - We had previously shown that three anti–Marburg virus nanobodies (VHH or single-domain antibody [sdAb]) targeted a cryptotope within an alpha-helical assembly at the nucleoprotein (NP) C-terminus that was conserved through half a century of viral evolution. Here, we wished to determine whether an anti–Ebola virus sdAb, that was cross-reactive within the Ebolavirus genus, recognized a similar structural feature upstream of the ebolavirus NP C-terminus. In addition, we sought to determine whether the specificities of a less cross-reactive anti–Zaire ebolavirus sdAb and a totally specific anti–Sudan ebolavirus sdAb were the result of exclusion from this region. Binding and X-ray crystallographic studies revealed that the primary determinant of cross-reactivity did indeed appear to be a preference for the helical feature. Specificity, in the case of the Zaire ebolavirus–specific sdAb, arose from the footprint shifting away from the helices to engage more variable residues. While both sdAbs used CDRs, they also had atypical side-on approaches, with framework 2 helping to accommodate parts of the epitope in sizeable paratope gullies. The Sudan ebolavirus–specific sdAb was more remarkable and appeared to bind two C-terminal domains simultaneously via nonoverlapping epitopes—“paratope duality.” One mode involved paratope gullying, whereas the other involved only CDRs, with CDR3 restructuring to wedge in between opposing walls of an interdomain crevice. The varied routes used by sdAbs to engage antigens discovered here deepen our appreciation of the small scaffold's architectural versatility and also reveal lucrative opportunities within the ebolavirus NP C-termini that might be leveraged for diagnostics and novel therapeutic targeting.
KW - Antibody–antigen recognition
KW - Filovirus
KW - Nanobody
KW - Restructuring
KW - Sudan ebolavirus
UR - http://www.scopus.com/inward/record.url?scp=85075903272&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85075903272&partnerID=8YFLogxK
U2 - 10.1016/j.jmb.2019.10.005
DO - 10.1016/j.jmb.2019.10.005
M3 - Article
C2 - 31626803
AN - SCOPUS:85075903272
SN - 0022-2836
VL - 431
SP - 4848
EP - 4867
JO - Journal of Molecular Biology
JF - Journal of Molecular Biology
IS - 24
ER -